Skip to main content
OpenTrials

Clinical trial condition

Polycythemia Vera

Explore clinical trials studying Polycythemia Vera. Study availability and eligibility vary by location and protocol.

207 public trials 35 recruiting studies
Refine in advanced search Browse all conditions

Polycythemia Vera trial results

Recruiting

Study of INCA036978 in Participants With Myeloproliferative Neoplasms

NCT07441694

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +13 more
Locations
  • University of Alabama At Birmingham Birmingham, Alabama, United States
  • City of Hope-Lennar Foundation Cancer Center Irvine, California, United States
  • Usc Norris Comprehensive Cancer Center Los Angeles, California, United States
  • UCLA Medical Hematology & Oncology Los Angeles, California, United States
View all 54 locations
View Trial Details
Recruiting

Observational Study on the Use of Ropeginterferon Alfa-2b in Polycythemia Vera (ROPEG-PV)

NCT06506084

Conditions
Bone Marrow Diseases, Bone Marrow Neoplasms, Hematologic Diseases, +6 more
Locations
  • SC Ematologia, ASST Papa Giovanni XXIII Bergamo, Lombardy, Italy
  • Divisione Ematologia ASST, Grande Ospedale Metropolitano Niguarda Milan, Lombardy, Italy
  • Divisione Ematologia, Fondazione IRCCS Policlinico San Matteo Pavia, Lombardy, Italy
  • U.O. Ematologia, Ospedale di Circolo e Fondazione Macchi Varese Varese, Lombardy, Italy
View all 37 locations
View Trial Details
Recruiting

A ELN-Multicenter Study on Phenotypic Evolution and Clinical Outcomes

NCT07203768

Conditions
Blood Platelet Disorders, Bone Marrow Diseases, Bone Marrow Neoplasms, +9 more
Locations
  • Mayo Clinic Rochester, Minnesota, United States
  • University Hospital Halle Halle, Germany
  • Hannover Medical School Hanover, Germany
  • University Clinic for Hematology, Oncology, Hemostaseology and Palliative Care Johannes Wesling Medical Center Minden, Germany
View all 24 locations
View Trial Details
Recruiting

INTREPID: A Study of Sapablursen Evaluating the Safety and Efficacy in Participants With Polycythemia Vera (PV)

NCT07429266

Conditions
Bone Marrow Diseases, Bone Marrow Neoplasms, Hematologic Diseases, +6 more
Locations
  • Regis Clinical Research LLC. Miami, Florida, United States
  • Florida Clinical Trials Group Plantation, Florida, United States
  • Florida Clinical Trials Group Tamarac, Florida, United States
  • The Center for Cancer & Blood Disorders Bethesda, Maryland, United States
View Trial Details
Recruiting

Registry of Older Patients With Cancer

NCT01137825

Conditions
Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +98 more
Locations
  • Seby B. Jones Cancer Center Boone, North Carolina, United States
  • Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill, North Carolina, United States
  • East Carolina University Greenville, North Carolina, United States
  • Pardee Cancer Center Hendersonville, North Carolina, United States
View Trial Details
Recruiting

A Phase 1 Study of PRT12396 in Participants With Select Myeloproliferative Neoplasms

NCT07469891

Conditions
Bone Marrow Diseases, Bone Marrow Neoplasms, Hematologic Diseases, +13 more
Locations
  • Colorado Blood Cancer Institute Denver, Colorado, United States
  • BRCR Global - Coral Springs Coral Springs, Florida, United States
  • START Midwest, LLC Grand Rapids, Michigan, United States
  • Thomas Jefferson University, Sidney Kimmel Cancer Center, Clinical Trials Office Philadelphia, Pennsylvania, United States
View Trial Details
Recruiting

A Phase 2, Open-Label Study of DISC-3405 in Participants With Polycythemia Vera (PV)

NCT06985147

Conditions
Bone Marrow Diseases, Bone Marrow Neoplasms, Hematologic Diseases, +7 more
Locations
  • Mayo Clinic in Arizona Phoenix, Arizona, United States
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
  • UCLA Health Los Angeles, California, United States
  • Keck Medicine of USC - Cancer Clinic- Newport Beach Newport Beach, California, United States
View all 15 locations
View Trial Details
Recruiting

MITHRIDATE: Ruxolitinib Versus Hydroxycarbamide or Interferon as First Line Therapy in High Risk Polycythemia Vera

NCT04116502

Conditions
Bone Marrow Diseases, Bone Marrow Neoplasms, Hematologic Diseases, +6 more
Locations
  • Aberdeen Royal Infirmary Aberdeen, United Kingdom
  • Royal United Hospital Bath, United Kingdom
  • Belfast City Hospital Belfast, United Kingdom
  • Birmingham Heartlands Hospital Birmingham, United Kingdom
View all 47 locations
View Trial Details

Related conditions